As it continues to grow its Cellular Therapy program for the treatment of blood cancers and non-malignant diseases, Tampa General Hospital (TGH) has recruited Dr. Megan Melody to the TGH Cancer Institute Cellular Therapy team. She joins Tampa General from the McGaw Medical Center of Northwestern University in Chicago.
Melody is a hematologist-oncologist specializing in blood cancers and cellular therapy. She is actively involved in clinical research, focusing on new immunotherapeutic strategies such as cellular therapies and bispecific antibodies for patients with lymphomas.
Melody earned her medical degree in 2018 from the USF Health Morsani College of Medicine, where she developed a deep interest in blood cancers. She completed her residency in internal medicine at the Mayo Clinic in Jacksonville, before finishing her fellowship in hematology and medical oncology at McGaw Medical Center of Northwestern University. While at Northwestern, she gained specialized training in the treatment of complex blood cancers, including leukemia, lymphoma and multiple myeloma, with a particular focus in cellular therapy.
